Evidence map›Paper›PMID 41506795›Full record

ArticleClinical medicine & research2025

Serum Squamous Cell Carcinoma Markers: A Case-Control Study for Cervical Cancer.

Bukola Catherine Oshikanlu, Anthonia Chima Sowunmi, Muhammad Y Habeebu, Adeyemi O Dada, Adisa R Oyesegun, Adeniyi A Adenipekun, Abbas A Abdus-Salam, Adewunmi O Alabi, Bolanle C Adegboyega, Eben Adepitan Aje and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical medicine & research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Bukola Catherine OshikanluDepartment of Radiation Oncology, NSIA-LUTH Cancer Centre, Lagos, Nigeria boshikanlu@nlcc.ng.
Anthonia Chima SowunmiDepartment of Radiation Oncology, NSIA-LUTH Cancer Centre, Lagos, Nigeria.
Muhammad Y HabeebuDepartment of Radiation Oncology, NSIA-LUTH Cancer Centre, Lagos, Nigeria.
Adeyemi O DadaDepartment of Chemical Pathology, Lagos State University Teaching Hospital, Lagos.
Adisa R OyesegunDepartment of Radiation Oncology, National Hospital Abuja, Federal Capital Territory, Nigeria.
Adeniyi A AdenipekunDepartment of Radiation Oncology, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Abbas A Abdus-SalamDepartment of Radiation Oncology, University of Ibadan and University College Hospital, Ibadan, Nigeria.
Adewunmi O AlabiDepartment of Radiation Oncology, NSIA-LUTH Cancer Centre, Lagos, Nigeria.
Bolanle C AdegboyegaDepartment of Radiation Oncology, NSIA-LUTH Cancer Centre, Lagos, Nigeria.
Eben Adepitan AjeDepartment of Radiation Oncology, NSIA-LUTH Cancer Centre, Lagos, Nigeria.
Adedayo OnitiloMarshfield Cancer Care and Research Center, Marshfield Clinic Health System (MCHS), Marshfield, Wisconsin, USA.
Abdul ShourEssentia Institute of Rural Health, Essentia, Duluth, Minnesota, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antigens, NeoplasmBiomarkers, TumorCarcinoma, Squamous CellSerpinsUterine Cervical NeoplasmsAdultAgedCase-Control StudiesChemoradiotherapyFemaleHumansMiddle AgedNeoplasm StagingTreatment OutcomeAntigens, NeoplasmBiomarkers, TumorSerpinssquamous cell carcinoma-related antigenCervixChemoradiotherapySerum SCC-AgSquamous Cell CarcinomaTreatment responseTumor biomarkers

Identifiers

PMID41506795
PMCPMC12782117

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.